Content Library

Expert guidance on classifying adverse vs. nonadverse nerve fiber degeneration in intrathecal oligonucleotide nonclinical toxicity studies.

Explore how early integration of toxicologic pathology can improve medical device safety, reduce miscommunication, and strengthen regulatory outcomes in device development.

Learn how integrating toxicologic pathology best practices into medical device evaluation can improve biological assessment, strengthen regulatory outcomes, and reduce study risk.

The road to bringing a medical device to market is fraught with potential regulatory pitfalls and decisions that can delay—or even derail—your efforts.

StageBio clients often ask for expert guidance when it comes to developing a protocol for the pathology work of their medical device studies. Senior Pathologist Lynette Phillips, DVM, PhD, DACVP, held a live webinar event to demystify several preclinical pathology operations which are crucial to a study’s success.